S-8 1 knwn_s8.htm FORM S-8 knwn_s8.htm

As filed with the Securities and Exchange Commission on August 5, 2025

 

Registration No. 333- ___

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

KNOW LABS, INC.

(Exact name of Registrant as specified in its charter)

 

 

Nevada

 

90-0273142

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

619 Western Avenue, Suite 610

Seattle, Washington 98104

(Address, including zip code, of Registrant’s principal executive office)

 

Know Labs, Inc. 2021 Equity Incentive Plan

(Full title of the plan)

 

Ronald P. Erickson, Chairman of the Board

Know Labs, Inc.

619 Western Avenue, Suite 610

Seattle, WA 98104

206-903-1351

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to: 

Jessica M. Lockett, Esq.

Corporate Securities Legal, LLP

650 Town Center Dr., Suite 680

Costa Mesa, CA 92626

(949) 752-1100

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

 

EXPLANATORY NOTE

 

This Registration Statement is filed by Know Labs, Inc. (the “Registrant”) for the purpose of registering an additional 48,950,000 shares of the Registrant’s common stock, par value $0.001 per share (the “Common Stock”) issuable under the Know Labs, Inc. 2021 Equity Incentive Plan (the “Plan”) following the amendment to the Plan that was approved by the Registrant’s stockholders at its special meeting of stockholders on July 31, 2025 (“Special Meeting”).

 

In accordance with Instruction E to Form S-8, the contents of the following prior registration statement on Form S-8, previously filed with the Securities and Exchange Commission (the “Commission”) with respect to the Plan, are hereby incorporated by reference: (i) 866,253 shares of Common Stock on Form S-8 filed with the Commission on December 10, 2021 (File No. 333-261597), and (ii) 550,000 shares of Common Stock on Form S-8 filed with the Commission on April 25, 2025 (File No. 333-286762) (collectively (i) and (ii), the “Prior Registration Statements”). The shares registered under the December 10, 2021 Registration Statement have been adjusted as referenced herein to reflect the Registrants 1-for-40 reverse stock split of the issued and outstanding shares of Common Stock which became effective on February 19, 2025.

 

Pursuant to General Instruction E of Form S-8, the contents of Prior Registration Statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

 

 
2

 

 

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

In accordance with the rules and regulations of the Commission, the information called for in Part I of Form S-8 is not being filed with or included in this Registration Statement or in a prospectus or prospectus supplement pursuant to Rule 424 of the Securities Act.

 

 
3

 

 

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8. Exhibits.

 

A list of exhibits included as part of this Registration Statement is set forth in the Exhibit Index to this Registration Statement and is incorporated herein by reference.

 

Exhibit

Number

 

Exhibit Description

 

 

 

 

 

 

 

Filed herewith

 

Incorporated by Reference herein from Form or Schedule

 

Filing Date

 

3.1

 

Restatement of the Articles of Incorporation, dated August 11, 2023

 

 

 

Form 8-K

 

August 14, 2023

 

3.2

 

Certificate of Amendment to the Articles of Incorporation, dated July 31, 2025

 

 

 

Form 8-K

 

August 1, 2025

 

3.3

 

Second Amended and Restated Bylaws, dated October 15, 2021

 

 

 

Form 8-K

 

December 7, 2021

 

4.1

 

Amendment to Know Labs Inc. 2021 Equity Incentive Plan, dated July 31, 2025

 

 

 

Form 8-K

 

August 1, 2025

 

4.2

 

2021 Know Labs, Inc. Equity Incentive Plan, as amended

 

x

 

 

 

 

 

5.1

 

Opinion of Corporate Securities Legal, LLP, filed herewith

 

x

 

 

 

 

 

23.1

 

Consent of BPM LLP, independent registered public accounting firm

 

x

 

 

 

 

 

23.2

 

Consent of Corporate Securities Legal, LLP (included in Exhibit 5.1)

 

x

 

 

 

 

 

24.1

 

Power of Attorney (included on signature page hereto)

 

x

 

 

 

 

 

107

 

Filing Fee Table

 

x

 

 

 

 

 

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Seattle, Washington, on August 5, 2025.

 

 

Know Labs, Inc.

 

 

 

 

Date: August 5, 2025

By:

/s/ Ronald P. Erickson

 

 

 

Ronald P. Erickson

 

 

 

Chief Executive Officer, and

Chairman of the Board of Directors

(Principal Executive Officer)

 

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ronald P. Erickson and Peter J. Conley and each or any one of them, their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for each of the undersigned in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities indicated:

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Ronald P. Erickson

 

Chief Executive Officer, and Director

 

August 5, 2025

Ronald P. Erickson

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Peter J. Conley

 

Chief Financial Officer

 

August 5, 2025

Peter J. Conley

 

(Principal Accounting Officer and

Principal Financial Officer)

 

 

 

 

 

 

 

/s/ William A. Owens

 

Director

 

August 5, 2025

William A. Owens

 

 

 

 

 

 

 

 

 

/s/ Jon Pepper

 

Director

 

August 5, 2025

Jon Pepper

 

 

 

 

 

 

 

 

 

/s/ Ichiro Takesako

 

Director

 

August 5, 2025

Ichiro Takesako

 

 

 

 

 

 

 

 

 

/s/ John Cronin

 

Director

 

August 5, 2025

John Cronin

 

 

 

 

 

 

 

 

 

/s/ Larry K, Ellingson

 

Director

 

August 5, 2025

Larry K. Ellingson

 

 

 

 

 

 
5